162(top 1%)
papers
6.2K(top 1%)
citations
40(top 1%)
h-index
73(top 1%)
g-index
167
all documents
6.5K
doc citations
1.6K
citing journals

Top Articles

#TitleJournalYearCitations
1EUCAST expert rules in antimicrobial susceptibility testingClinical Microbiology and Infection2013527
2The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST SubcommitteeClinical Microbiology and Infection2017428
3Development of the quinolonesJournal of Antimicrobial Chemotherapy2003393
4Linezolid-Induced Inhibition of Mitochondrial Protein SynthesisClinical Infectious Diseases2006270
5The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approachClinical Microbiology and Infection2012232
6Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infectionsJournal of Antimicrobial Chemotherapy2003189
7European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testingClinical Microbiology and Infection2006176
8Establishing MIC breakpoints and the interpretation of in vitro susceptibility testsJournal of Antimicrobial Chemotherapy2001166
9Fluoroquinolone AntibioticsDrugs1988141
10Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance ProgrammeJournal of Antimicrobial Chemotherapy2004126
11Rapid Identification of Major Escherichia coli Sequence Types Causing Urinary Tract and Bloodstream InfectionsJournal of Clinical Microbiology2015121
12ACTIVITY OF VARIOUS ANTIMICROBIAL AGENTS AGAINST L MONOCYTOGENESLancet, The1990103
13Continuous Infusion of ??-Lactam AntibioticsClinical Pharmacokinetics199891
14Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06Journal of Antimicrobial Chemotherapy200886
15Tigecycline pharmacokinetic/pharmacodynamic updateJournal of Antimicrobial Chemotherapy200880
16Activities of Moxifloxacin against, and Emergence of Resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an In Vitro Pharmacokinetic ModelAntimicrobial Agents and Chemotherapy200372
17Theatre over-shoes do not reduce operating theatre floor bacterial countsJournal of Hospital Infection199169
18Mupirocin-resistant Staphylococcus aureusLancet, The199066
19Growth in the use of antibiotics in the community in England and Scotland in 1980-93BMJ: British Medical Journal199666
20The effect of surgical approach on blood flow to the femoral head during resurfacingJournal of Bone and Joint Surgery: British Volume200764
21Interactions between aminoglycoside antibiotics and carbenicillin or ticarcillinInfection197662
22Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06Journal of Antimicrobial Chemotherapy200862
23A review of the pharmacokinetics and pharmacodynamics of aztreonamJournal of Antimicrobial Chemotherapy201661
24A systematic review of matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry compared to routine microbiological methods for the time taken to identify microbial organisms from positive blood culturesEuropean Journal of Clinical Microbiology and Infectious Diseases201557
25Fosfomycin trometamolJournal of Antimicrobial Chemotherapy199455
26Mupirocin-resistant Staphylococcus aureusLancet, The199254
27Typing of Listeria spp. by random amplified polymorphic DNA (RAPD) analysisJournal of Medical Microbiology199354
28Listeria faecal carriage by renal transplant recipients, haemodialysis patients and patients in general practice: its relation to season, drug therapy, foreign travel, animal exposure and dietEpidemiology and Infection199153
29The antibacterial efficacy of levofloxacin and ciprofloxacin against Pseudomonas aeruginosaassessed by combining antibiotic exposure and bacterial susceptibilityJournal of Antimicrobial Chemotherapy199952
30Developments in PK/PD: optimising efficacy and prevention of resistance. A critical review of PK/PD in in vitro modelsInternational Journal of Antimicrobial Agents200251
31Analyses of teicoplanin concentrations from 1994 to 2006 from a UK assay serviceJournal of Antimicrobial Chemotherapy201049
32The use of in vitro pharmacodynamic models of infection to optimize fluoroquinolone dosing regimensJournal of Antimicrobial Chemotherapy200047
33The effect of quinolone antibacterials on the gastrointestinal flora compared with that of other antibacterialsJournal of Antimicrobial Chemotherapy198646
34Moxifloxacin (Bay 12-8039): a new methoxy quinolone antibacterialExpert Opinion on Investigational Drugs199945
35The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic/pharmacodynamic model experimentsInternational Journal of Antimicrobial Agents201545
36Population structure ofEscherichia colicausing bacteraemia in the UK and Ireland between 2001 and 2010Journal of Antimicrobial Chemotherapy201645
37The in-vitro degradation at 37°C of vancomycin in serum, CAPD fluid and phosphate-buffered salineJournal of Antimicrobial Chemotherapy198844
38In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and β-haemolytic streptococciJournal of Antimicrobial Chemotherapy199944
39Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratoryInternational Journal of Antimicrobial Agents200644
40Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06Journal of Antimicrobial Chemotherapy200842
41Absorption of oral ofloxacin after cytotoxic chemotherapy for haematological malignancyJournal of Antimicrobial Chemotherapy199341
42Survey, laboratory and statistical methods for the BSAC Resistance Surveillance ProgrammesJournal of Antimicrobial Chemotherapy200841
43Bactericidal Activity of Multiple Combinations of Tigecycline and Colistin against NDM-1-Producing EnterobacteriaceaeAntimicrobial Agents and Chemotherapy201241
44Risk Factors for Treatment Failure and Mortality among Hospitalised Patients with Complicated Urinary Tract Infection: A Multicentre Retrospective Cohort Study, RESCUING Study GroupClinical Infectious Diseases201840
45Determination of bone and fat concentrations following systemic cefamandole and regional cefuroxime administration in patients undergoing knee arthroplastyJournal of Antimicrobial Chemotherapy199039
46In vitro assessment of colistin's antipseudomonal antimicrobial interactions with other antibioticsClinical Microbiology and Infection199939
47AAC(1): a new aminoglycoside-acetylating enzyme modifying the Cl aminogroup of apramycinJournal of Antimicrobial Chemotherapy198737
48Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactamBritish Journal of Urology199536
49The use and therapeutic drug monitoring of teicoplanin in the UKClinical Microbiology and Infection200436
50Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infectionsAntimicrobial Resistance and Infection Control201834